Cover Image
Market Research Report

Generic Injectables Market (Large Molecule Injectables (Biosimilars), Small Molecule Injectables) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published by Transparency Market Research Product code 635229
Published Content info 203 Pages
Delivery time: 1-2 business days
Price
Back to Top
Generic Injectables Market (Large Molecule Injectables (Biosimilars), Small Molecule Injectables) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Published: April 19, 2018 Content info: 203 Pages
Description

Title:
Generic Injectables Market (Product Type - Large Molecule Injectables (Biosimilars), Small Molecule Injectables; Container Type - Vials, Ampoules, Premixes, Prefilled Syringes; Injectables Market - Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology; Route of Administration - Intravenous, Intramuscular, Subcutaneous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Generic Injectables Market - Overview

This comprehensive report by Transparency Market Research analyzes the global generic injectables market for the period between 2017 and 2025. An in-depth and unbiased market assessment has been made, which offers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in manufacturing and distribution of generic injectable products as well as new entrants planning to enter this market.

The global generic injectables market has been studied for the forecast period of 2017 to 2025. For research, 2016 has been considered as the base year and 2015 as the historical year, while all forecasts have been provided from 2017 to 2025. The global generic injectables market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global generic injectables market for 2016. The report also provides detail company profiles of emerging market players operating in the global generic injectables market.

The market overview section comprises factors such as key market dynamics including drivers, restraints, and opportunities affecting the demand for generic injectable products in the global market. These factors are likely to aid stakeholders establish a strong foothold in the global generic injectables market. Furthermore, the market overview section comprises key industry events, product overview, and market attractiveness analysis in the global generic injectables market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Generic Injectables Market - Scope

The global generic injectables market has been segmented based on product type, container type applications, and route of administration. In terms of product type, the global generic injectables market has been bifurcated into large molecule injectables, also known as generic biologics or biosimilar products, and small molecule injectables. The large molecule injectables segment has been further sub-segmented into monoclonal antibodies {monoclonal antibodies (mAbs)}, insulin, and others. Based on container type, the global generic injectables market has been categorized into vials, ampoules, premixes, prefilled syringes, and others. In terms of application, the global generic injectables market has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. Based on route of administration, the global generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others.

In terms of geography, the global generic injectables market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, Brazil, Mexico, South Africa, Israel, and GCC Countries has also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the generic injectables market in various regions has been provided in this section.

The report renders a detailed outline/blueprint of the generic injectables market globally that is expected to assist new companies establish their presence and market players expand their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments.

Competitive landscape

Major players operating in the global generic injectables market include Pfizer Inc., Novartis AG (Sandoz International GmbH), Baxter, Fresenius SE & Co. KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC., Lupin Ltd., and Sanofi, Biocon. Other prominent players operating in the global generic injectables market include Dr. Reddy's Laboratories, Aurobindo Pharma, Sagent Pharmaceuticals Inc., Zydus Cadila, GlaxoSmithKline plc, and AstraZeneca plc.

The global generic injectables market has been segmented into:

Global Generic Injectables Market, by Product Type,

  • Large Molecule Injectables (Biosimilars)
  • Small Molecule Injectables

Global Generic Injectables Market, by Container Type,

  • Vials
  • Ampoules
  • Premixes
  • Prefilled Syringes
  • Others

Global Generic Injectables Market, by Application

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Diabetes
  • Immunology
  • Others

Global Generic Injectables Market, by Route of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Others

Global Generic Injectables Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentations
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Generic Injectables Market Analysis and Forecasts, 2015-2025
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis
  • 4.6. Market Outlook
  • 4.7. Global Generic Products Market Condition Overview: by Key Countries
  • 4.8. Biosimilars: Pipeline Analysis
  • 4.9. Generic Injectables Market: Mergers & Acquisitions
  • 4.10. Global Generics: Industry Trends
  • 4.11. EU and USFDA Approved Biosimilar Products Snapshot
  • 4.12: Regulatory Framework for Biosimilar Products

4.13: Top 10 Players in the U.S. Generic Injectables Market: Company Share Analysis and Market Competition Overview Per Product

  • 4.14. Challenges Faced by Biosimilar Products to be Approved in the U.S. Market

5. Global Generic Injectables Market Analysis and Forecasts, by Product Type,

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Market Value Forecast by Product Type, 2015-2025
    • 5.3.1. Large Molecule Injectables (Biosimilars)
      • 5.3.1.1. Monoclonal Antibodies (mAbs)
      • 5.3.1.2. Insulin
      • 5.3.1.3. Others
    • 5.3.2. Small Molecule Injectables
  • 5.4. Market Attractiveness by Product Type

6. Global Generic Injectables Market Analysis and Forecasts, by Container Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast by Container Type, 2015-2025
    • 6.3.1. Vials
    • 6.3.2. Premixes
    • 6.3.3. Prefilled Syringes
    • 6.3.4. Ampoules
    • 6.3.5. Other
  • 6.4. Market Attractiveness by Container Type

7. Global Generic Injectables Market Analysis and Forecasts, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast by Application, 2015-2025
    • 7.3.1. Oncology
    • 7.3.2. Infectious Diseases
    • 7.3.3. Cardiology
    • 7.3.4. Diabetes
    • 7.3.5. Immunology
    • 7.3.6. Others
  • 7.4. Market Attractiveness by Route of Administration

8. Global Generic Injectables Market Analysis and Forecasts, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast by Route of Administration, 2015-2025
    • 8.3.1. Intravenous
    • 8.3.2. Intramuscular
    • 8.3.3. Subcutaneous
    • 8.3.4. Others
  • 8.4. Market Attractiveness, by Route of Administration

9. Global Generic Injectables Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Country/ Sub-region

10. North America Global Generic Injectables Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product Type, 2015-2025
    • 10.2.1. Large Molecule Injectables (Biosimilars)
      • 10.2.1.1. Monoclonal Antibodies (mAbs)
      • 10.2.1.2. Insulin
      • 10.2.1.3. Others
    • 10.2.2. Small Molecule Injectables
  • 10.3. Market Value Forecast, by Container Type, 2015-2025
    • 10.3.1. Vials
    • 10.3.2. Premixes
    • 10.3.3. Prefilled Syringes
    • 10.3.4. Ampoules
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Application, 2015-2025
    • 10.4.1. Oncology
    • 10.4.2. Infectious Diseases
    • 10.4.3. Cardiology
    • 10.4.4. Diabetes
    • 10.4.5. Immunology
    • 10.4.6. Others
  • 10.5. Market Value Forecast, by Route of Administration, 2015-2025
    • 10.5.1. Intravenous
    • 10.5.2. Intramuscular
    • 10.5.3. Subcutaneous
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2015-2025
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Container Type
    • 10.7.3. By Route of Administration
    • 10.7.4. By Route of Administration
    • 10.7.5. By Country

11. Europe Global Generic Injectables Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2015-2025
    • 11.2.1. Large Molecule Injectables (Biosimilars)
      • 11.2.1.1. Monoclonal Antibodies (mAbs)
      • 11.2.1.2. Insulin
      • 11.2.1.3. Others
    • 11.2.2. Small Molecule Injectables
  • 11.3. Market Value Forecast, by Container Type, 2015-2025
    • 11.3.1. Vials
    • 11.3.2. Premixes
    • 11.3.3. Prefilled Syringes
    • 11.3.4. Ampoules
    • 11.3.5. Other
  • 11.4. Market Value Forecast, by Application, 2015-2025
    • 11.4.1. Oncology
    • 11.4.2. Infectious Diseases
    • 11.4.3. Cardiology
    • 11.4.4. Diabetes
    • 11.4.5. Immunology
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by Route of Administration, 2015-2025
    • 11.5.1. Intravenous
    • 11.5.2. Intramuscular
    • 11.5.3. Subcutaneous
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2015-2025
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Spain
    • 11.6.5. Italy
    • 11.6.6. Russia
    • 11.6.7. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Container Type
    • 11.7.3. By Application
    • 11.7.4. By Route of Administration
    • 11.7.5. By Country

12. Asia Pacific Global Generic Injectables Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2015-2025
    • 12.2.1. Large Molecule Injectables (Biosimilars)
      • 12.2.1.1. Monoclonal Antibodies (mAbs)
      • 12.2.1.2. Insulin
      • 12.2.1.3. Others
    • 12.2.2. Small Molecule Injectables
  • 12.3. Market Value Forecast, by Container Type, 2015-2025
    • 12.3.1. Vials
    • 12.3.2. Premixes
    • 12.3.3. Prefilled Syringes
    • 12.3.4. Ampoules
    • 12.3.5. Other
  • 12.4. Market Value Forecast, by Application, 2015-2025
    • 12.4.1. Oncology
    • 12.4.2. Infectious Diseases
    • 12.4.3. Cardiology
    • 12.4.4. Diabetes
    • 12.4.5. Immunology
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by Route of Administration, 2015-2025
    • 12.5.1. Intravenous
    • 12.5.2. Intramuscular
    • 12.5.3. Subcutaneous
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country, 2015-2025
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Container Type
    • 12.7.3. By Route of Administration
    • 12.7.4. By Route of Administration
    • 12.7.5. By Country

13. Latin America Global Generic Injectables Market Analysis and Forecast

  • 13.1.Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2015-2025
    • 13.2.1. Large Molecule Injectables (Biosimilars)
      • 13.2.1.1. Monoclonal Antibodies (mAbs)
      • 13.2.1.2. Insulin
      • 13.2.1.3. Others
    • 13.2.2. Small Molecule Injectables
  • 13.3. Market Value Forecast, by Container Type, 2015-2025
    • 13.3.1. Vials
    • 13.3.2. Premixes
    • 13.3.3. Prefilled Syringes
    • 13.3.4. Ampoules
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Application, 2015-2025
    • 13.4.1. Oncology
    • 13.4.2. Infectious Diseases
    • 13.4.3. Cardiology
    • 13.4.4. Diabetes
    • 13.4.5. Immunology
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by Route of Administration, 2015-2025
    • 13.5.1. Intravenous
    • 13.5.2. Intramuscular
    • 13.5.3. Subcutaneous
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country, 2015-2025
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Container Type
    • 13.7.3. By Route of Administration
    • 13.7.4. By Route of Administration
    • 13.7.5. By Country

14. Middle East & Africa Global Generic Injectables Market Analysis and Forecast

  • 14.1.Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2015-2025
    • 14.2.1. Large Molecule Injectables (Biosimilars)
      • 14.2.1.1. Monoclonal Antibodies (mAbs)
      • 14.2.1.2. Insulin
      • 14.2.1.3. Others
    • 14.2.2. Small Molecule Injectables
  • 14.3. Market Value Forecast, by Container Type, 2015-2025
    • 14.3.1. Vials
    • 14.3.2. Premixes
    • 14.3.3. Prefilled Syringes
    • 14.3.4. Ampoules
    • 14.3.5. Other
  • 14.4. Market Value Forecast, by Application, 2015-2025
    • 14.4.1. Oncology
    • 14.4.2. Infectious Diseases
    • 14.4.3. Cardiology
    • 14.4.4. Diabetes
    • 14.4.5. Immunology
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by Route of Administration, 2015-2025
    • 14.5.1. Intravenous
    • 14.5.2. Intramuscular
    • 14.5.3. Subcutaneous
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country, 2015-2025
    • 14.6.1. GCC Countries
    • 14.6.2. Israel
    • 14.6.3. South Africa
    • 14.6.4. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Container Type
    • 14.7.3. By Route of Administration
    • 14.7.4. By Route of Administration
    • 14.7.5. By Country

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis by Company (2016)
  • 15.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.3.1. Pfizer Inc.
      • 15.3.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.1.2 Financial Overview
      • 15.3.1.3 Product Portfolio
      • 15.3.1.4 SWOT Analysis
      • 15.3.1.5 Strategic Overview
    • 15.3.2. Novartis AG (Sandoz International GmbH)
      • 15.3.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.2.2 Financial Overview
      • 15.3.2.3 Product Portfolio
      • 15.3.2.4 SWOT Analysis
    • 15.3.3. Baxter
      • 15.3.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.3.2 Financial Overview
      • 15.3.3.3 Product Portfolio
      • 15.3.3.4 SWOT Analysis
      • 15.3.3.5 Strategic Overview
    • 15.3.4. Fresenius SE & Co. KGaA
      • 15.3.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.4.2 Financial Overview
      • 15.3.4.3 Product Portfolio
      • 15.3.4.4 SWOT Analysis
      • 15.3.4.5 Strategic Overview
    • 15.3.5. Mylan N.V.
      • 15.3.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.5.2 Financial Overview
      • 15.3.5.3 Product Portfolio
      • 15.3.5.4 SWOT Analysis
      • 15.3.5.5 Strategic Overview
    • 15.3.6. Teva Pharmaceutical Industries Ltd.
      • 15.3.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.6.2 Financial Overview
      • 15.3.6.3 Product Portfolio
      • 15.3.6.4 SWOT Analysis
      • 15.3.6.5 Strategic Overview
    • 15.3.7. Hikma Pharmaceuticals PLC.
      • 15.3.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.7.2 Financial Overview
      • 15.3.7.3 Product Portfolio
      • 15.3.7.4 SWOT Analysis
      • 15.3.7.5 Strategic Overview
    • 15.3.8. Lupin Ltd.
      • 15.3.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.8.2 Financial Overview
      • 15.3.8.3 Product Portfolio
      • 15.3.8.4 SWOT Analysis
      • 15.3.8.5 Strategic Overview
    • 15.3.9. Sanofi
      • 15.3.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.9.2 Financial Overview
      • 15.3.9.3 Product Portfolio
      • 15.3.9.4 SWOT Analysis
      • 15.3.9.5 Strategic Overview
    • 15.3.10. Biocon
      • 15.3.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
      • 15.3.10.2 Financial Overview
      • 15.3.10.3 Product Portfolio
      • 15.3.10.4 SWOT Analysis
      • 15.3.10.5 Strategic Overview

List of Tables

  • Table 01 Global Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 02 Global Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 03 Global Generic Injectables Market Size Value (US$ Mn) Forecast, by Application, 2015-2025
  • Table 04 Global Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 05 Global Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 06 Global Generic Injectables Market Size Value (US$ Mn) Forecast, by Region, 2015-2025
  • Table 07 North America Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 08 North America Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 09 North America Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 10 North America Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015-2025
  • Table 11 North America Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 12 North America l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 13 Europe Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 14 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 15 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 16 Europe Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015-2025
  • Table 17 Europe Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 18 Europe l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 19 Asia Pacific Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 20 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 21 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 22 Asia Pacific Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015-2025
  • Table 23 Asia Pacific Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 24 Asia Pacific l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 25 Latin America Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 26 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 27 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 28 Latin America Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015-2025
  • Table 29 Latin America Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 30 Latin America l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 31 Middle East & Africa Generic Injectables Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 32 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 33 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Large Molecule Injectables, 2015-2025
  • Table 34 Middle East & Africa Generic Injectables Market Size Value (US$ Mn) Forecast, by Container Type, 2015-2025
  • Table 35 Middle East & Africa Generic Injectables Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 36 Middle East & Africa l Generic Injectables Market Size (US$ Mn) Forecast, by Route of Administration, 2015-202

List of Figures

  • Figure 01 Global Generic Injectables Market Snapshot
  • Figure 02 Global Generic Injectables Market Size Value (US$ Mn) Forecast, 2015-2025
  • Figure 03 Market Value Share (%), by Product Type (2016)
  • Figure 04 Market Value Share (%), by Container Type (2016)
  • Figure 05 Market Value Share (%), by Route Of Administration (2016)
  • Figure 06 Market Value Share (%), by Application (2016 )
  • Figure 07 Global Generic Injectables Market Value Share Analysis (%), by Product Type, 2017 and 2025
  • Figure 08 Global Generic Injectables Market Attractiveness Analysis, by Product Type, 2017-2025
  • Figure 09 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Large Molecule Injectables, 2015-2025
  • Figure 10 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Small Molecule Injectables, 2015-2025
  • Figure 11 Global Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 12 Global Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 13 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vials, 2015-2025
  • Figure 14 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ampoules, 2015-2025
  • Figure 15 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Premixes, 2015-2025
  • Figure 16 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Prefilled Syringes, 2015-2025
  • Figure 17 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2015-2025
  • Figure 18 Global Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 19 Global Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 20 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diabetes, 2017-2025
  • Figure 21 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Diseases, 2017-2025
  • Figure 22 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiology, 2017-2025
  • Figure 23 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diabetes, 2017-2025
  • Figure 24 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Immunology, 2017-2025
  • Figure 25 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2025
  • Figure 26 Global Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 27 Global Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
  • Figure 28 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2017-2025
  • Figure 29 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2017-2025
  • Figure 30 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2017-2025
  • Figure 31 Global Generic Injectables Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2025
  • Figure 32 Global Generic Injectables Market Value Share (%), by Region, 2017 and 2025
  • Figure 33 Global Generic Injectables Market Attractiveness, by Region, 2017-2025
  • Figure 34 North America Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 35 North America Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 36 North America Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
  • Figure 37 North America Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
  • Figure 38 North America Generic Injectables Market Attractiveness, by Product Type, 2017-2025
  • Figure 39 North America Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 40 North America Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 41 North America Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 42 North America Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 43 North America Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 44 North America Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
  • Figure 45 Europe Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 46 Europe Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 47 Europe Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
  • Figure 48 Europe Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
  • Figure 49 Europe Generic Injectables Market Attractiveness, by Product Type, 2017-2025
  • Figure 50 Europe Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 51 Europe Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 52 Europe Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 53 Europe Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 54 Europe Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 55 Europe Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
  • Figure 56 Asia Pacific Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 57 Asia Pacific Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 58 Asia Pacific Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
  • Figure 59 Asia Pacific Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
  • Figure 60 Asia Pacific Generic Injectables Market Attractiveness, by Product Type, 2017-2025
  • Figure 61 Asia Pacific Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 62 Asia Pacific Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 63 Asia Pacific Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 64 Asia Pacific Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 65 Asia Pacific Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 66 Asia Pacific Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
  • Figure 67 Latin America Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 68 Latin America Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 69 Latin America Generic Injectables Market Attractiveness Analysis, by Country,2017-2025
  • Figure 70 Latin America Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
  • Figure 71 Latin America Generic Injectables Market Attractiveness, by Product Type, 2017-2025
  • Figure 72 Latin America Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 73 Latin America Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 74 Latin America Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 75 Latin America Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 76 Latin America Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 77 Latin America Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
  • Figure 78 Middle East & Africa Generic Injectables Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 79 Middle East & Africa Generic Injectables Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 80 Middle East & Africa Generic Injectables Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 81 Middle East & Africa Generic Injectables Market Value Share (%), by Product Type, 2017 and 2025
  • Figure 82 Middle East & Africa Generic Injectables Market Attractiveness, by Product Type, 2017-2025
  • Figure 83 Middle East & Africa Generic Injectables Market Value Share (%), by Container Type, 2017 and 2025
  • Figure 84 Middle East & Africa Generic Injectables Market Attractiveness, by Container Type, 2017-2025
  • Figure 85 Middle East & Africa Generic Injectables Market Value Share (%), by Application, 2017 and 2025
  • Figure 86 Middle East & Africa Generic Injectables Market Attractiveness, by Application, 2017-2025
  • Figure 87 Middle East & Africa Generic Injectables Market Value Share (%), by Route of Administration, 2017 and 2025
  • Figure 88 Middle East & Africa Generic Injectables Market Attractiveness, by Route of Administration, 2017-2025
Back to Top